Genpact Limited

Valuation Analysis

About the Company

Genpact Limited provides business process outsourcing and information technology services in India, the rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers customer onboarding, customer service, collections, retail and commercial loan operations, payment operations, mortgage origination and servicing, compliance, wealth management, capital market operations support, financial crime and risk management, proprietary insurance policy suite, underwriting support, new business processing, policy administration, customer, claims management, catastrophe and exposure/risk modeling, actuarial services, end-to-end third-party administration for proper

Genpact Limited Stock at a Glance

Genpact Limited (G) is currently trading at $32.06 with a market capitalization of $5.4B. The trailing P/E ratio stands at 9.83x, with a forward P/E of 7.16x. The 52-week range spans from $28.78 to $48.64; the current price is 34.1% below the yearly high. Year-over-year revenue growth stands at +6.7%. The net profit margin stands at 11.04%.

💰 Dividend

Genpact Limited pays an annual dividend of $0.75 per share, representing a yield of 2.34%. The payout ratio stands at 21.4%.

📊 Analyst Rating

11 analysts rate Genpact Limited (G) on consensus: Buy. The average price target is $42.45, implying +32.42% from the current price. Analyst price targets range from $32.00 to $58.00.

Genpact Limited: The Investment Case in Detail

Genpact Limited (G) operates in the Technology — specifically Information Technology Services — and is headquartered in Bermuda. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Wall Street consensus sits at Buy with an average price target implying roughly 32.42% upside from current levels — analyst sentiment is firmly constructive. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

The Bear Case

Short interest sits at 12.46% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valuation in Context

The PEG ratio at 1.16 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric. The EV/EBITDA multiple of 7.24x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

What to Watch Next

• The forward P/E of 7.16x is meaningfully below the trailing 9.83x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 32.42% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (12.46%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Genpact Limited?

Compare top-rated brokers — low fees, trusted providers, fully regulated.